[{"address1": "680 East Colorado Boulevard", "address2": "Suite 180", "city": "Pasadena", "state": "CA", "zip": "91101", "country": "United States", "phone": "631 830 7092", "fax": "631 982 5050", "website": "https://lixte.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Lixte Biotechnology Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on identifying targets for cancer drug development, and developing and commercializing cancer therapies. Its lead product candidate, LB-100 is in phase 1b clinical trials combined with Atezolizumab for patients with microsatellite stable metastatic colorectal cancer. The company's LB-100 combined with doxorubicin in advanced soft tissue sarcoma is under Phase 1b portion; and LB-100 combined with dostarlimab that is in phase 1b/2 for ovarian clear cell carcinoma. The company has a clinical trial research agreement with the Netherlands Cancer Institute; collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group; and a development collaboration agreement with the Netherlands Cancer Institute. Lixte Biotechnology Holdings, Inc. was founded in 2005 and is based in Pasadena, California.", "fullTimeEmployees": 2, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert Neal Weingarten", "age": 72, "title": "CFO, VP & Secretary", "yearBorn": 1952, "fiscalYear": 2023, "totalPay": 175000, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.8327, "open": 0.83, "dayLow": 0.7467, "dayHigh": 0.85, "regularMarketPreviousClose": 0.8327, "regularMarketOpen": 0.83, "regularMarketDayLow": 0.7467, "regularMarketDayHigh": 0.85, "payoutRatio": 0.0, "beta": 0.368, "volume": 77411, "regularMarketVolume": 77411, "averageVolume": 30690, "averageVolume10days": 89000, "averageDailyVolume10Day": 89000, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 2093574, "fiftyTwoWeekLow": 0.64, "fiftyTwoWeekHigh": 3.0, "fiftyDayAverage": 1.252, "twoHundredDayAverage": 1.68285, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 4208880, "profitMargins": 0.0, "floatShares": 2523701, "sharesOutstanding": 2684070, "sharesShort": 10145, "sharesShortPriorMonth": 19714, "sharesShortPreviousMonthDate": 1745971200, "dateShortInterest": 1748563200, "sharesPercentSharesOut": 0.0038, "heldPercentInsiders": 0.18431999, "heldPercentInstitutions": 0.15843001, "shortRatio": 0.62, "shortPercentOfFloat": 0.0038, "impliedSharesOutstanding": 2684070, "bookValue": -0.872, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -3324198, "trailingEps": -1.45, "lastSplitFactor": "1:10", "lastSplitDate": 1685923200, "52WeekChange": -0.68799996, "SandP52WeekChange": 0.09544468, "quoteType": "EQUITY", "currentPrice": 0.78, "recommendationKey": "none", "totalCash": 1384697, "totalCashPerShare": 0.516, "totalDebt": 0, "quickRatio": 3.899, "currentRatio": 4.264, "returnOnAssets": -0.81143, "returnOnEquity": -1.5513699, "freeCashflow": -1725609, "operatingCashflow": -2943794, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "LIXT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "longName": "Lixte Biotechnology Holdings, Inc.", "regularMarketChangePercent": -6.32882, "regularMarketPrice": 0.78, "marketState": "CLOSED", "shortName": "Lixte Biotechnology Holdings, I", "exchange": "NCM", "messageBoardId": "finmb_29181356", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 30690, "fiftyTwoWeekLowChange": 0.13999999, "fiftyTwoWeekLowChangePercent": 0.21874999, "fiftyTwoWeekRange": "0.64 - 3.0", "fiftyTwoWeekHighChange": -2.22, "fiftyTwoWeekHighChangePercent": -0.74, "fiftyTwoWeekChangePercent": -68.799995, "dividendDate": 1605830400, "earningsTimestamp": 1747053000, "earningsTimestampStart": 1754510400, "earningsTimestampEnd": 1754942400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.45, "fiftyDayAverageChange": -0.472, "fiftyDayAverageChangePercent": -0.37699682, "twoHundredDayAverageChange": -0.90285003, "twoHundredDayAverageChangePercent": -0.5365006, "priceToBook": -0.8944954, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1193319000000, "corporateActions": [], "postMarketTime": 1750453095, "regularMarketTime": 1750449602, "postMarketChangePercent": -3.80769, "postMarketPrice": 0.7503, "postMarketChange": -0.0297, "regularMarketChange": -0.0527, "regularMarketDayRange": "0.7467 - 0.85", "displayName": "Lixte Biotechnology", "trailingPegRatio": null, "__fetch_time": "2025-06-21"}]